Sotera Health (SHC)
(Delayed Data from NSDQ)
$11.29 USD
-0.12 (-1.05%)
Updated May 17, 2024 04:00 PM ET
After-Market: $11.30 +0.01 (0.09%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth D Momentum B VGM
Price, Consensus and EPS Surprise
SHC 11.29 -0.12(-1.05%)
Will SHC be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for SHC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SHC
Sotera Health Company (SHC) Misses Q1 Earnings and Revenue Estimates
Sotera Health Company (SHC) Reports Next Week: Wall Street Expects Earnings Growth
SHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sotera Health Company (SHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Sotera Health Company (SHC) Meets Q4 Earnings Estimates
Unveiling Sotera Health Company (SHC) Q4 Outlook: Wall Street Estimates for Key Metrics
Other News for SHC
UK shareholder meetings calendar - next 7 days
Sotera Health Seeks Refinancing Amid Market Uncertainties
LONDON BROKER RATINGS: JPMorgan puts B&M on 'negative catalyst watch'
LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral
KBW Issues a Hold Rating on Shore Bancshares (SHBI)